113 related articles for article (PubMed ID: 12734658)
21. Genetic mutual relationship between PTEN and p53 in gastric cancer.
Oki E; Tokunaga E; Nakamura T; Ueda N; Futatsugi M; Mashino K; Yamamoto M; Watanabe M; Ikebe M; Kakeji Y; Baba H; Maehara Y
Cancer Lett; 2005 Sep; 227(1):33-8. PubMed ID: 16051030
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
[TBL] [Abstract][Full Text] [Related]
23. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells.
Perren A; Komminoth P; Saremaslani P; Matter C; Feurer S; Lees JA; Heitz PU; Eng C
Am J Pathol; 2000 Oct; 157(4):1097-103. PubMed ID: 11021813
[TBL] [Abstract][Full Text] [Related]
24. Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation.
Reifenberger J; Rauch L; Beckmann MW; Megahed M; Ruzicka T; Reifenberger G
Br J Dermatol; 2003 May; 148(5):1040-6. PubMed ID: 12786840
[TBL] [Abstract][Full Text] [Related]
25. PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma.
Inaba F; Kawamata H; Teramoto T; Fukasawa I; Inaba N; Fujimori T
Oncol Rep; 2005 Jan; 13(1):17-24. PubMed ID: 15583796
[TBL] [Abstract][Full Text] [Related]
26. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
28. PTEN and other tumor suppressor gene mutations as secondary genetic alterations in synovial sarcoma.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2004 May; 11(5):1011-5. PubMed ID: 15069540
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma.
Baldinu P; Cossu A; Manca A; Satta MP; Pisano M; Casula M; Dessole S; Pintus A; Tanda F; Palmieri G
Cancer; 2002 Jun; 94(12):3157-68. PubMed ID: 12115348
[TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer.
Su TH; Chang JG; Perng LI; Chang CP; Wei HJ; Wang NM; Tsai CH
Gynecol Oncol; 2000 Feb; 76(2):193-9. PubMed ID: 10637069
[TBL] [Abstract][Full Text] [Related]
31. Gliomatosis cerebri: neurobehavioral and neuropathological observations.
Filley CM; Kleinschmidt-DeMasters BK; Lillehei KO; Damek DM; Harris JG
Cogn Behav Neurol; 2003 Sep; 16(3):149-59. PubMed ID: 14501536
[TBL] [Abstract][Full Text] [Related]
32. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.
Kurose K; Gilley K; Matsumoto S; Watson PH; Zhou XP; Eng C
Nat Genet; 2002 Nov; 32(3):355-7. PubMed ID: 12379854
[TBL] [Abstract][Full Text] [Related]
33. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
34. Array-based comparative genomic hybridization and immunohistochemical studies in gliomatosis cerebri.
Min HS; Kim B; Park SH
J Neurooncol; 2008 Dec; 90(3):259-66. PubMed ID: 18704270
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri.
Kirches E; Mawrin C; Schneider-Stock R; Krause G; Scherlach C; Dietzmann K
J Neurooncol; 2003 Jan; 61(1):1-5. PubMed ID: 12587789
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
Bigner SH; Matthews MR; Rasheed BK; Wiltshire RN; Friedman HS; Friedman AH; Stenzel TT; Dawes DM; McLendon RE; Bigner DD
Am J Pathol; 1999 Aug; 155(2):375-86. PubMed ID: 10433931
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
[TBL] [Abstract][Full Text] [Related]
38. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas.
Mizoguchi M; Nutt CL; Mohapatra G; Louis DN
Brain Pathol; 2004 Oct; 14(4):372-7. PubMed ID: 15605984
[TBL] [Abstract][Full Text] [Related]
40. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
